Real-world use of mycophenolate mofetil in inflammatory bowel disease: Results from the ENEIDA registry

• Published in: Digestive and liver disease Vol. 54; no. 5; pp. 635 - 641
• Main Authors: Hernández-Camba, A., Arranz, L., Vera, I., Carpio, D., Calafat, M., Lucendo, A.J., Taxonera, C., Marín, S., Garcia, M.J., Marín, G. Suris, Rodríguez, E. Sánchez, Carbajo, A.Y., De Castro, M.L., Iborra, M., Martin-Cardona, A., Rodríguez-Lago, I., Busquets, D., Bertoletti, F., Ausín, M. Sierra, Tardillo, C., Malaves, J. Huguet, Bujanda, L., Castaño, A., Domènech, E., Ramos, L., Merino, O.
• Format: Journal Article
• Language: English
• Published: Netherlands Elsevier Ltd 01.05.2022
• Subjects: Chronic Disease; Colitis, Ulcerative - drug therapy; Crohn Disease - drug therapy; Crohn's disease; Humans; Inflammatory bowel disease; Inflammatory Bowel Diseases - drug therapy; Mycophenolate mofetil; Mycophenolic Acid - therapeutic use; Registries; Ulcerative colitis; Inflammatory bowel disease; Crohn's disease; Mycophenolate mofetil; Ulcerative colitis

Studies to evaluate the use of mycophenolate mofetil (MMF) in inflammatory bowel disease (IBD) are limited after the appearance of biological treatments. Our primary objective was to evaluate the effectiveness and safety of MMF in IBD. IBD patients who had received MMF were retrieved from the ENEIDA...